Wolfe Research Initiates Coverage of Tyra Biosciences (TYRA) with Peer Perform Recommendation

Wolfe Research initiated coverage of Tyra Biosciences (NasdaqGS:TYRA) on May 19, 2026 with a Peer Perform rating. Fintel notes an analyst price forecast implying 52.23% upside, but the initiation itself is a neutral, non-event recommendation. The article is primarily analyst commentary rather than a fundamental company update.

Analysis

Wolfe Research initiated coverage of Tyra Biosciences (NasdaqGS:TYRA) on May 19, 2026 with a Peer Perform rating. Fintel notes an analyst price forecast implying 52.23% upside, but the initiation itself is a neutral, non-event recommendation. The article is primarily analyst commentary rather than a fundamental company update.